Y Intercept (Hong Kong) LTD Novo Nordisk A S Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 125,081 shares of NVO stock, worth $10.5 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
125,081
Previous 41,717
199.83%
Holding current value
$10.5 Million
Previous $4.97 Million
116.61%
% of portfolio
0.75%
Previous 0.32%
Shares
12 transactions
Others Institutions Holding NVO
# of Institutions
1,879Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.67 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.3 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.09 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.06 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.02 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $189B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...